ASX - Delayed Quote AUD

EVE Health Group Limited (EVE.AX)

0.0010 0.0000 (0.00%)
At close: April 9 at 1:32 PM GMT+10
Loading Chart for EVE.AX
DELL
  • Previous Close 0.0010
  • Open 0.0010
  • Bid --
  • Ask 0.0010 x 1659440000
  • Day's Range 0.0010 - 0.0010
  • 52 Week Range 0.0010 - 0.0010
  • Volume 100,000
  • Avg. Volume 88,695
  • Market Cap (intraday) 5.274M
  • Beta (5Y Monthly) 1.11
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0000
  • Earnings Date Feb 28, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Eve Health Group Limited, together with its subsidiaries, engages in the production and distribution of nutrition, health, and wellness products in Australia, New Zealand, the Asia Pacific, and North America. It provides organic tea tree oils; and distributes botanical oils, as well as supplies essential oils, hydrosols, extracts, carrier oils, and seed oils. The company also offers organic raw honey and raw honey probiotic concentrates; and contract manufacturing services. In addition, it offers medical nutrition solutions for chronic and lifestyle diseases, including Gluco Smooth for type 2 diabetes that reduces the post-meal blood sugar levels; and dietary interventions. The company was formerly known as EVE Investments Limited. Eve Health Group Limited was incorporated in 2003 and is based in Subiaco, Australia.

www.evehealthgroup.com.au

--

Full Time Employees

June 30

Fiscal Year Ends

Related News

Performance Overview: EVE.AX

Trailing total returns as of 4/19/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

EVE.AX
0.00%
S&P/ASX 200 [XJO]
0.31%

1-Year Return

EVE.AX
0.00%
S&P/ASX 200 [XJO]
2.74%

3-Year Return

EVE.AX
81.54%
S&P/ASX 200 [XJO]
7.10%

5-Year Return

EVE.AX
80.00%
S&P/ASX 200 [XJO]
20.89%

Compare To: EVE.AX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: EVE.AX

Valuation Measures

As of 4/19/2024
  • Market Cap

    5.27M

  • Enterprise Value

    5.50M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.65

  • Price/Book (mrq)

    2.42

  • Enterprise Value/Revenue

    2.64

  • Enterprise Value/EBITDA

    -3.19

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -157.88%

  • Return on Assets (ttm)

    -24.83%

  • Return on Equity (ttm)

    -50.04%

  • Revenue (ttm)

    2.28M

  • Net Income Avi to Common (ttm)

    -1.99M

  • Diluted EPS (ttm)

    -0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    112.06k

  • Total Debt/Equity (mrq)

    15.58%

  • Levered Free Cash Flow (ttm)

    -2.59M

People Also Watch